European Journal of Clinical Pharmacology

, Volume 33, Issue 2, pp 211–214 | Cite as

Pharmacokinetics of temazepam after day-time and night-time oral administration

  • F. O. Müller
  • M. Van Dyk
  • H. K. L. Hundt
  • A. L. Joubert
  • H. G. Luus
  • G. Groenewoud
  • G. C. Dunbar
Short Communications


The pharmacokinetic disposition of temazepam was compared after a day-time and night-time dose in an open randomised crossover study. Twelve healthy male volunteers received a single oral dose of 20 mg temazepam in a soft gelatine capsule at 0900 h or 2200 h. Blood samples were taken immediately before dosing and at selected times over the 36-h period after each dose.

The absorption of temazepam was slower after evening administration; the absorption half-life and time to reach maximal plasma concentration being 0.53 h and 1.67 h respectively, compared to 0.38 h and 1.02 h following morning administration. Considering distribution characteristics, evening administration produced a lower peak plasma temazepam concentration (362 ng/ml) compared with a day-time level of 510 ng/ml. Distribution half-life after night-time administration was increased compared with day-time administration (1.76 h vs 1.03 h). A significantly higher percentage of the drug, relative to Cmax, remained in the plasma at 8 and 24 h after evening dosing (39.3 and 15.4% compared to 24.7 and 11.2% following day-time administration). In spite of the half-lives of absorption, distribution and elimination all being longer after the evening dose, the overall bioavailability, as measured by the area under the curve (AUC) was comparable after the two times of administration. Similarly the difference in the mean residence time (MRT) of the two doses was within accepted limits.

It is concluded that a chronopharmacokinetic effect was seen for temazepam; however it is unlikely to be of any clinical significance.

Key words

temazepam pharmacokinetics oral dose distribution half-life 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fillingham JM (1979) Double-blind evaluation of the efficacy and safety of temazepam in outpatients with insomnia. Br J Clin Pharmacol 8: 73S-78SGoogle Scholar
  2. 2.
    Heffron WA, Roth P (1979) Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients. Br J Clin Pharmacol 8: 695–725Google Scholar
  3. 3.
    Mitler NM, Carskadon MA, Phillips RL, Sterling WR, Zarcone VP, Spiegel R, Guilleminault C, Dement WC (1979) Hypnotic efficacy of temazepam: A long-term sleep laboratory evaluation. Br J Clin Pharmacol 8: 63S-68SGoogle Scholar
  4. 4.
    Smith RB, Kroboth PD, Phillips JP (1986) Temporal variation in trizolam pharmacokinetics after oral administration. J Clin Pharmacol 26: 120–124Google Scholar
  5. 5.
    Nakano S, Watanabe H, Nagi K, Ogawa N (1984) Circadian stage-dependent changes in diazepam kinetics. Clin Pharmacol Ther 36: 271–277Google Scholar
  6. 6.
    Steinijans VW, Diletti E (1983) Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals. Eur J Clin Pharmacol 24: 127–136Google Scholar
  7. 7.
    Fuccella LM, Bolcioni G, Tamassi V, Ferrario L, Tognoni G (1977) Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol 12: 383–386Google Scholar
  8. 8.
    Kiotz U, Ziegler G (1982) Physiologic and temporal variation in hepatic elimination of midazolam. Clin Pharmacol Ther 32: 107–112Google Scholar
  9. 9.
    Hilbert JM, Chung M, Maier G, Gural R, Symchowicz S, Sampaglione N (1984) Effect of sleep on quazepam kinetics. Clin Pharmacol Ther 36: 99–104Google Scholar
  10. 10.
    Beary MD, Lacey JH, Crutchfield MB, Bhat AN (1984) Psychosocial stress insomnia and temazepam: A sleep laboratory evaluation in a “general practice” sample. Psychopharmacology 83: 17–19Google Scholar
  11. 11.
    Nicholson AN, Stone BM (1976) Effect of a metabolite of diazepam 3-hydroxy-diazepam (temazepam) on sleep in men. Br J Clin Pharmacol 3: 543–550Google Scholar
  12. 12.
    Frithz G, Groppi W (1981) Temazepam versus nitrazepam: A comparative trial with treatment of sleep disturbances. J Int Med Res 9: 338–342Google Scholar
  13. 13.
    Griffiths AN, Tedeshi G, Richens A (1986) The effects of repeated doses of temazepam and nitrazepam on several measures of human performance. Acta Psychiatr Scand 74 [Suppl 332]: 119–126Google Scholar
  14. 14.
    Moon CAL, Hindmarch I (1983) The effects of a hypnotic, temazepam, on aspects of sleep and performance following waking of shift workers. Drugs Exp Clin Res 9: 849–852Google Scholar
  15. 15.
    Nicholson AN, Roth T, Stone BM (1985) Hypnotics and aircrew. Aviat Space Environ Med 56: 299–303Google Scholar
  16. 16.
    O'Hanlon JF, Volkerts ER (1986) Hypnotics and actual driving performance. Acta Psychiatr Scand 74 [Suppl 332]: 95–104Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • F. O. Müller
    • 1
  • M. Van Dyk
    • 1
  • H. K. L. Hundt
    • 1
  • A. L. Joubert
    • 1
  • H. G. Luus
    • 1
  • G. Groenewoud
    • 1
  • G. C. Dunbar
    • 2
    • 3
  1. 1.Department of PharmacologyUniversity of the Orange Free StateBloemfonteinSouth Africa
  2. 2.Clinical Research and OperationsWyeth Research (UK)TaplowEngland
  3. 3.Beecham PharmaceuticalsGreat Burgh, EpsomEngland

Personalised recommendations